Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)
scientific article published on 15 November 2011
Author/s
author: Sergio Amadori, Adriano Venditti, Francesco Di Raimondo, Francesca Chiarini, Marco Vignetti, Livio Pagano, Emanuele Ammatuna, Paola Fazi, Monia Lunghi, Giovanni Martinelli, Giovanna Meloni, Daniela Cilloni, Luciana Annino
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.